Austerity in Portugal drops drug bill 21%, drives parallel exports, hospital debt
This article was originally published in Scrip
Executive Summary
Market conditions in Portugal are continuing to deteriorate as cost cutting has fuelled parallel exports and hospitals owe companies increasingly more money, APIFARMA, the local R&D-based pharmaceutical industry association, has warned.